AFC in Practice: The Latest Changes in Hemp and Cannabis Regulations

Dr William Scott Grob, CAMS-FCI, CGSS, FRM, CAIA, is the Director of Research and Analysis, responsible for promoting quantitative research methods. He has built customized programs, such as the two Illegal Wildlife Trade certificates developed with the WWF & WJC and the two Ending Modern Slavery & Human Trafficking with the FAST Initiative & Polaris. Previously, he was the ACAMS AML Director for the Americas and Asia. Dr. Grob has over 25 years of financial and banking expertise. His most recent role was as Regional Head of Affiliates Management, HSBC, where he worked on mitigating financial crime and correspondent banking risks across Asia. His 12-year career at the bank also included managing risk within the Equity/FX prime brokerage business, Structured Funds business, and Hedge Fund units.

Mr. Kemmerling is the CEO and Founder of CRB Monitor, which empowers financial institutions to manage risk and monetize opportunity in emerging, high-risk industries including Cannabis and Crypto.  Our best-in-class cannabis corporate intelligence platform identifies, categorizes and monitors 95,000+ Businesses, 250,000+ cannabis licenses, 146,000+ Owners, and 1,400+ Securities directly related to the industry.  Clients utilize our data for screening, EDD/KYC, initial on-boarding, on-going monitoring, deal-originations and market/risk analysis.  Our database(s) can be accessed via our on-line UI, API integrations and bulk datafeeds, including integrations with multiple KYC software and data partners.  Clients include commercial banks with over $5.5 trillion in assets.

Gillian Schauer, PhD, MPH is the Executive Director of the Cannabis Regulators Association - a nonpartisan, nonprofit association that convenes, educates, and supports government agencies regulating cannabis, cannabinoids, and hemp across more than 45 states and U.S. territories, Canada, and the Netherlands. Dr. Schauer was elected CANNRA’s first Executive Director in 2021, and served as a Senior Advisor to CANNRA before the association’s founding. She has spoken internationally on the regulatory landscape and regulatory needs related to hemp-derived cannabinoids, including testifying on the issue before the U.S. House Committee on Oversight and Accountablity's Health Care and Financial Services Subcommittee.

Dr. Schauer has worked in public health and policy for two decades, and has more than a decade of experience working with federal and state agencies on cannabis policy, data monitoring, and research translation. Prior to working on cannabis policy, Dr. Schauer worked on tobacco control policy. She was the Senior Editor on the 2020 Surgeon General’s Report on Smoking Cessation. Dr. Schauer is an affiliate researcher at the University of Washington and has more than 75 peer-reviewed research publications on cannabis and other substances. She has a PhD from Emory University, a Master of Public Health from University of Washington, and a Bachelors of Science from Northwestern University.